至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides.

FASEB J.. 2018-09; 
ZhanJian,JiaHusen,SemchenkoEvgeny A,BianYunqiang,ZhouAmy M,LiZhixiu,YangYuedong,WangJihua,SarkarSohinee,TotsikaMakrina,BlanchardHelen,JenFreda E-C,YeQizhuang,HaselhorstThomas,JenningsMichael P,SeibKate L,ZhouY
Products/Services Used Details Operation
Peptide Synthesis … MATERIALS AND METHODS Peptides The peptides shown in Supplemental Table S1 were synthe- sized by Genscript (Piscataway, NJ, USA) at.95% purity with N-terminal acetylation and C-terminal amidation. Enzyme activity assay … Get A Quote

摘要

Bacterial infection is one of the leading causes of death in young, elderly, and immune-compromised patients. The rapid spread of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs to control MDR pathogens. We describe a heretofore-unexplored discovery pathway for novel antibiotics that is based on self-targeting, structure-disrupting peptides. We show that a helical peptide, KFF- EcH3, derived from the Escherichia coli methionine aminopeptidase can disrupt secondary and tertiary structure of this essential enzyme, thereby killing the bacterium (including MDR strains). Significantly, no detectable resistance developed against this peptide. Based on a ... More

关键词

Escherichia coli,Neisseria gonorrhoeae,antibiotic resistance,protein-specific denatura